(Reuters) - NEW YORK, July 19 - Wyeth on Thursday reported higher-than-expected second-quarter earnings on strong sales growth of its prescription drugs, and it raised its profit forecast for the year.
The drug maker said it earned $1.2 billion, or 87 cents per share, up from $1.06 billion, or 78 cents per share, a year earlier.
Read more at Reuters.com Market News
The drug maker said it earned $1.2 billion, or 87 cents per share, up from $1.06 billion, or 78 cents per share, a year earlier.
Read more at Reuters.com Market News
No comments:
Post a Comment